Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Sientra stock price, quote, forecast and news

SIEN
US82621J1051
A12EE3

Price

0.08
Today +/-
+0
Today %
+0 %
P

Sientra stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Sientra stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Sientra stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Sientra stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Sientra's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Sientra Stock Price History

DateSientra Price
4/23/20240.08 undefined
4/22/20240.07 undefined

Sientra Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Sientra, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sientra from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sientra’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sientra. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sientra’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sientra’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sientra’s growth potential.

Sientra Revenue, EBIT and net profit per share

DateSientra RevenueSientra EBITSientra Net Income
2026e169.29 M undefined-48.98 M undefined-10.61 M undefined
2025e107.44 M undefined-10.71 M undefined-13.46 M undefined
2024e94.56 M undefined-17.34 M undefined-22.65 M undefined
2023e89.62 M undefined-33.76 M undefined-48.67 M undefined
202290.55 M undefined-69.05 M undefined-73.31 M undefined
202180.68 M undefined-46.35 M undefined-62.48 M undefined
202055 M undefined-47.02 M undefined-89.95 M undefined
201983.7 M undefined-89.81 M undefined-106.82 M undefined
201868.13 M undefined-79.77 M undefined-82.63 M undefined
201736.54 M undefined-52.89 M undefined-64.03 M undefined
201620.73 M undefined-40.03 M undefined-40.17 M undefined
201538.11 M undefined-24.25 M undefined-41.23 M undefined
201444.73 M undefined-5.79 M undefined-5.81 M undefined
201335.17 M undefined-18.21 M undefined-19.13 M undefined
201210.45 M undefined-23.43 M undefined-23.43 M undefined

Sientra Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201220132014201520162017201820192020202120222023e2024e2025e2026e
10354438203668835580908994107169
-250.0025.71-13.64-47.3780.0088.8922.06-33.7345.4512.50-1.115.6213.8357.94
80.0074.2975.0071.0565.0061.1160.2960.2456.3655.0045.56----
8263327132241503144410000
-23-18-5-24-40-52-79-89-47-46-69-33-17-10-48
-230.00-51.43-11.36-63.16-200.00-144.44-116.18-107.23-85.45-57.50-76.67-37.08-18.09-9.35-28.40
-23-19-5-41-40-64-82-106-89-62-73-48-22-13-10
--17.39-73.68720.00-2.4460.0028.1329.27-16.04-30.3417.74-34.25-54.17-40.91-23.08
1.421.421.491.581.821.922.544.075.025.717.180000
---------------
Details

Keystats

ⓘ

Revenue and Growth

The Sientra Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Sientra is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20122013201420152016201720182019202020212022
                     
39.29.796.7112.867.226.686.987.65551.826.1
3.46.15.24.23.16.622.527.523.533.136.9
00009.4000000
10.721.520.220.618.520.924.139.648.652.942.7
0.90.91.81.51.91.52.62.52.232.1
54.238.2123.9139.1100.155.6136.1157.2129.3140.8107.8
0.30.30.61.434.82.519.920.420.621.9
00000000000
00000000000
0.30.20.10.16.218.816.517.49.428.825.7
14.314.314.304.912.512.59.29.29.29.2
300200200200200600700700700600800
15.21515.21.714.336.732.247.239.759.257.6
69.453.2139.1140.8114.492.3168.3204.4169200165.4
                     
150.5150.50.20.20.20.20.30.50.50.60.1
1.51.8229.8294.2299.1307.2428.9550.6558.1661.8694.4
-109.1-128.2-134-175.3-215.4-279.5-362.1-468.9-558.9-621.3-694.7
0000000000-0.82
00000000000
42.924.196119.183.927.967.182.2-0.341.1-1.02
2.94.82.64.13.65.813.29.46.57.46.8
22.24.14.64.73.98.813.217.714.211.611
1.34.99.811.82011.130.936.945.258.772.5
00000000000
003.80024.66.96.54.82.30
26.413.820.820.627.550.364.270.570.78090.3
015.121.700027.938.360.662.555.4
000000010010000
0.10.611.43.114.29.413.738.216.620.1
0.115.722.71.43.114.237.352.198.979.175.5
26.529.543.52230.664.5101.5122.6169.6159.1165.8
69.453.6139.5141.1114.592.4168.6204.8169.3200.2164.78
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Sientra provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Sientra's financial health and stability.

Assets

Sientra's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Sientra must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Sientra after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Sientra's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20122013201420152016201720182019202020212022
-23-19-5-41-40-64-82-106-67-62-73
00001333356
00000000000
-11-1223022-15-9-99
453185122031122121
00110034444
00000000000
-29-250-18-34-45-56-87-60-42-34
000-1-1-10-4-3-4-3
0-180-1-12-200-22-43-3
0-1800-11-180-17080
00000000000
01510-2602510113534
64080621110910913814
64148735125117109313512
---3.00---1.00-2.00-10.00-4.00-5.00-6.00
00000000000
34-298716-45-40600-32-3-25
-30.24-25.950.01-19.31-35.56-47.74-57.05-91.1-64.1-47.3-38.46
00000000000

Sientra stock margins

The Sientra margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sientra. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sientra.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sientra's sales revenue. A higher gross margin percentage indicates that the Sientra retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sientra's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sientra's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sientra's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sientra. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sientra's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sientra Margin History

Sientra Gross marginSientra Profit marginSientra EBIT marginSientra Profit margin
2026e45.93 %-28.93 %-6.27 %
2025e45.93 %-9.97 %-12.53 %
2024e45.93 %-18.34 %-23.95 %
2023e45.93 %-37.67 %-54.31 %
202245.93 %-76.26 %-80.96 %
202154.96 %-57.45 %-77.44 %
202057.09 %-85.49 %-163.55 %
201960.56 %-107.3 %-127.62 %
201860.62 %-117.08 %-121.28 %
201761.22 %-144.75 %-175.23 %
201666.81 %-193.1 %-193.78 %
201572.03 %-63.63 %-108.19 %
201474.29 %-12.94 %-12.99 %
201375.58 %-51.78 %-54.39 %
201277.51 %-224.21 %-224.21 %

Sientra Stock Sales Revenue, EBIT, Earnings per Share

The Sientra earnings per share therefore indicates how much revenue Sientra has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sientra earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sientra's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sientra’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sientra's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sientra Revenue, EBIT and net profit per share

DateSientra Sales per ShareSientra EBIT per shareSientra Earnings per Share
2026e14.15 undefined0 undefined-0.89 undefined
2025e8.98 undefined0 undefined-1.13 undefined
2024e7.91 undefined0 undefined-1.89 undefined
2023e7.49 undefined0 undefined-4.07 undefined
202212.61 undefined-9.62 undefined-10.21 undefined
202114.13 undefined-8.12 undefined-10.94 undefined
202010.96 undefined-9.37 undefined-17.92 undefined
201920.57 undefined-22.07 undefined-26.25 undefined
201826.82 undefined-31.41 undefined-32.53 undefined
201719.03 undefined-27.55 undefined-33.35 undefined
201611.39 undefined-21.99 undefined-22.07 undefined
201524.12 undefined-15.35 undefined-26.09 undefined
201430.02 undefined-3.89 undefined-3.9 undefined
201324.77 undefined-12.82 undefined-13.47 undefined
20127.36 undefined-16.5 undefined-16.5 undefined

Sientra business model

Sientra Inc is a leading company in the medical industry specializing in the manufacturing of medical implants and devices. The company was founded in 2007 with headquarters in Santa Barbara, California. It has steadily grown since its establishment and is now a key global player in its market segment. The founders of Sientra had a vision to create a company that specializes in providing high-quality implants and devices for aesthetic surgery, particularly catering to the needs of discerning customers considering such procedures. Due to the success of its business model, the company has undergone several foreign stock listings, raising a significant amount of capital. Sientra has also made multiple acquisitions to expand its services and products and strengthen its position in the industry. Sientra offers a wide range of implants and other medical devices for aesthetic surgery, including breast implants, buttock implants, and facial implants. The Sientra brand is synonymous with highest quality and safety in the manufacturing of these implants. Sientra's products are also significant in other important surgical procedures. For example, the company also offers surgical sutures that are crucial in wound healing. These sutures have been specifically developed by Sientra for the most demanding surgical interventions and are the top choice for many leading surgeons worldwide. Sientra also has a comprehensive research and development team constantly introducing new and innovative products to the market. The company has particularly dedicated itself to developing new medical products for breast tissue restoration. These products not only enhance the appearance of the breast but also support the regeneration process of breast tissue. In addition to its use in aesthetic surgery, Sientra has also developed products for breast tissue reconstruction. These products have been specifically designed for women who have undergone mastectomy due to breast cancer or other conditions. The company has been strongly committed to preserving breast health and supporting women affected by breast cancer. Sientra's approach to aesthetic surgery is to help all individuals achieve a better appearance. The company places great emphasis on the safety and sustainability of its products. There have been numerous cases where cheaper, inferior implants from other companies have led to complications and serious health issues. Sientra has a clear vision of achieving the highest quality and effectiveness in aesthetic surgery. Through continuous commitment and constant product development, Sientra has strengthened its position as a leading company in the medical industry. The company has successfully established itself in an extremely demanding and competitive market and has earned a high reputation through its products and services. Ultimately, Sientra is a company dedicated to innovation, reliability, and customer satisfaction. It aims to provide patients with a safe and satisfactory outcome while always maintaining the highest standards. Sientra is one of the most popular companies on Eulerpool.com.

Sientra SWOT Analysis

Strengths

Sientra Inc holds a strong position in the market as a leading manufacturer and marketer of medical aesthetics products. The company offers a comprehensive range of breast implants and other surgical and non-surgical products, providing a competitive advantage. Sientra has built a reputable brand image known for its high-quality products, innovative technology, and dedication to patient safety.

Weaknesses

Sientra faces certain weaknesses that may hinder its growth potential in the market. One significant weakness is the company's heavy reliance on its breast implant business, which exposes it to potential fluctuations in demand and regulatory risks. Additionally, Sientra's limited global presence compared to its competitors restricts its market reach and growth opportunities. Addressing these weaknesses will be crucial to ensure long-term sustainability and diversification.

Opportunities

Sientra has several opportunities to capitalize on for future growth and expansion. The rising global demand for aesthetic procedures presents a significant market opportunity, which the company can leverage by expanding its product offerings and diversifying into new markets. Furthermore, technological advancements in the industry open doors for innovative product development, allowing Sientra to differentiate itself and gain a competitive edge. Strategic partnerships and collaborations with healthcare professionals and institutions can also enhance market penetration and brand recognition.

Threats

Sientra faces a range of threats that may impact its business operations and market position. Regulatory challenges and potential changes in industry regulations can create uncertainties and barriers to entry. Intense competition from other established players in the aesthetics industry poses a threat to Sientra's market share and growth prospects. Economic downturns and reduced consumer discretionary spending could also impact the demand for aesthetic procedures and products. It is crucial for Sientra to proactively manage these threats through effective risk management strategies and proactive monitoring of market trends.

Sientra Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Sientra Revenue by Segment

Segmente2020201920182017
Breast product---31.49 M USD
Breast product55 M USD-37.02 M USD-
Miradry16.24 M USD-31.11 M USD5.06 M USD
Breast product-46.36 M USD--
Miradry-37.34 M USD--

Sientra Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Sientra Revenue by Segment

DateInternationalNorth AmericaOther Countries
20222.45 M USD88.1 M USD-
2021-79.04 M USD1.65 M USD
202012.49 M USD58.75 M USD-
201921.42 M USD62.28 M USD-
201818.15 M USD49.98 M USD-
20173.07 M USD33.47 M USD-

Sientra Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Sientra historical P/E ratio, EBIT, and P/S ratio.

Sientra shares outstanding

The number of shares was Sientra in 2023 — This indicates how many shares 7.18 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sientra earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sientra's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sientra’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sientra's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sientra Stock splits

In Sientra's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Sientra.

Sientra latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2023-0.89 -1.31  (-47.06 %)2023 Q3
6/30/2023-0.88 -0.85  (3.47 %)2023 Q2
3/31/2023-1.25 -1.06  (15.05 %)2023 Q1
12/31/2022-1.37 -2.35  (-71.93 %)2022 Q4
9/30/2022-2.31 -2.4  (-3.81 %)2022 Q3
6/30/2022-2.32 -2.9  (-25.17 %)2022 Q2
3/31/2022-2.42 -2.9  (-19.89 %)2022 Q1
12/31/2021-1.95 -2.7  (-38.28 %)2021 Q4
9/30/2021-2.13 -0.8  (62.4 %)2021 Q3
6/30/2021-2.22 -3.5  (-57.76 %)2021 Q2
1
2
3
4

Sientra list of shareholders

%
Name
Stocks
Change
Date
8.84170 % Wells Fargo Advisors1,057,467655,52712/31/2023
4.74157 % Pessin (Norman H)567,092567,09211/9/2022
2.72216 % The Vanguard Group, Inc.325,570-4,02212/31/2023
2.10785 % Casdin (Alexander W)252,099252,0996/15/2023
0.86971 % Geode Capital Management, L.L.C.104,0179,13212/31/2023
0.73161 % Pessin (Brian L)87,50087,50011/9/2022
0.67739 % RTW Investments L.P.81,016-223,02012/31/2023
0.65398 % BlackRock Institutional Trust Company, N.A.78,216012/31/2023
0.57564 % Hightower Advisors, LLC68,847-26,47312/31/2023
0.39553 % Menezes (Ronald)47,305-3,62511/13/2023
1
2
3
4
5
...
10

Sientra Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Berkshire Hathaway B Stock
Berkshire Hathaway B
SupplierCustomer0,120,69-0,35-0,84-0,81-0,23
Avantor Stock
Avantor
SupplierCustomer-0,140,110,810,910,540,17
1

Most common questions regarding Sientra

What values and corporate philosophy does Sientra represent?

Sientra Inc represents values of innovation, quality, and patient satisfaction. As a leading medical aesthetics company, Sientra is committed to providing cutting-edge solutions and exceptional experiences to its customers. With a focus on safety and efficacy, the company strives to deliver premium products for breast augmentation and body contouring procedures. Sientra's corporate philosophy revolves around empowering patients and surgeons alike by offering state-of-the-art technologies and comprehensive support. By prioritizing excellence, transparency, and patient-centricity, Sientra Inc aims to revolutionize the field of aesthetic medicine while ensuring the utmost satisfaction and confidence in its products and services.

In which countries and regions is Sientra primarily present?

Sientra Inc is primarily present in the United States.

What significant milestones has the company Sientra achieved?

Sientra Inc, a leading medical aesthetics company, has achieved several significant milestones. Firstly, the company received FDA approval for its breast implants, establishing its presence in the market. Additionally, Sientra launched its miraDry system, a revolutionary non-invasive treatment for excessive underarm sweating. The company also expanded its product portfolio by introducing various innovative solutions for breast reconstruction and augmentation, emphasizing their commitment to patient satisfaction. Furthermore, Sientra successfully completed clinical studies, further solidifying their reputation as a pioneer in the industry. With these notable achievements, Sientra Inc continues to enhance its position as a trusted provider of high-quality aesthetic products and services.

What is the history and background of the company Sientra?

Sientra Inc is a renowned American medical aesthetics company, specializing in breast implants and other associated products. Founded in 2007, Sientra Inc has built a solid reputation for its innovative solutions and commitment to patient safety. The company is headquartered in Santa Barbara, California, and has evolved into a leader in the field of plastic surgery, serving both cosmetic and reconstructive surgeons. Sientra Inc prides itself on its advanced technology, high-quality products, and dedication to customer satisfaction. With a strong emphasis on research and development, Sientra Inc continues to make significant contributions to the aesthetics industry.

Who are the main competitors of Sientra in the market?

Some of the main competitors of Sientra Inc in the market include Allergan plc, Mentor Worldwide LLC, and Johnson & Johnson.

In which industries is Sientra primarily active?

Sientra Inc is primarily active in the industries of medical devices, aesthetics, and plastic surgery.

What is the business model of Sientra?

The business model of Sientra Inc revolves around providing innovative and high-quality products and services in the medical aesthetics field. As a leading company in the industry, Sientra Inc specializes in developing, manufacturing, and marketing a wide range of products including breast implants, body contouring implants, and facial implants. Their comprehensive portfolio caters to both cosmetic and reconstructive plastic surgery markets, offering surgeons and patients with innovative solutions for enhancing and restoring aesthetics. Sientra Inc's commitment to research, development, and customer satisfaction has positioned them as a trusted and reliable partner for plastic surgeons and patients seeking safe and effective aesthetic solutions.

What is the P/E ratio of Sientra 2024?

The Sientra P/E ratio is -0.02.

What is the P/S ratio of Sientra 2024?

The Sientra P/S ratio is 0.01.

What is the AlleAktien quality score of Sientra?

The AlleAktien quality score for Sientra is 4/10.

What is the revenue of Sientra 2024?

The expected Sientra revenue is 94.56 M USD.

How high is the profit of Sientra 2024?

The expected Sientra profit is -22.65 M USD.

What is the business model of Sientra

Sientra Inc is a leading manufacturer and provider of innovative products for aesthetic surgery and reconstructive surgery. The company is headquartered in Santa Barbara, California and specializes in the development and distribution of high-quality breast implants, breast reconstruction products, and other aesthetic surgeries. The business model of Sientra is based on a combination of research, development, and marketing of products that meet the needs of patients and surgeons. The company offers a wide range of products as well as services to support and facilitate aesthetic surgeries. The production of breast implants, one of Sientra's main business areas, is a complex and highly specialized process. The company has a range of implants made from different materials, including silicone implants and breast implants in anatomical, round, and microtextured forms. Each implant is designed to have different sizes and shapes to meet the individual needs of patients. Another important business area of Sientra is breast reconstruction, which plays a significant role in restoring self-confidence and control over one's own life, especially for women who have undergone mastectomy due to breast cancer. Sientra offers a wide range of products to meet the needs of patients and surgeons. In addition to the production of breast implants and breast reconstruction products, the company also offers a wide range of services. This includes training and support for surgeons in using the products, as well as assistance for patients in making decisions about surgery and postoperative care. Sientra aims to provide excellent service and high-quality products to its customers. The company has a strong brand awareness and offers innovative, top-of-the-line products in a growing and demanding market that is constantly evolving. Sientra relies on a combination of research, development, marketing, and sales to meet the needs of all stakeholders. In summary, Sientra follows a successful business model based on a combination of high-quality products and services. The company offers its customers a wide range of products and services that are designed to meet the needs of patients and surgeons. Sientra is committed to expanding its market position and strengthening its brand awareness in order to remain a successful and leading provider of innovative aesthetic surgery.

What is the Sientra dividend?

Sientra pays a dividend of 0 USD distributed over payouts per year.

How often does Sientra pay dividends?

The dividend cannot currently be calculated for Sientra or the company does not pay out a dividend.

What is the Sientra ISIN?

The ISIN of Sientra is US82621J1051.

What is the Sientra WKN?

The WKN of Sientra is A12EE3.

What is the Sientra ticker?

The ticker of Sientra is SIEN.

How much dividend does Sientra pay?

Over the past 12 months, Sientra paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sientra is expected to pay a dividend of 0 USD.

What is the dividend yield of Sientra?

The current dividend yield of Sientra is .

When does Sientra pay dividends?

Sientra pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sientra?

Sientra paid dividends every year for the past 0 years.

What is the dividend of Sientra?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sientra located?

Sientra is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sientra kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sientra from 9/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did Sientra pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of Sientra in the year 2023?

In the year 2023, Sientra distributed 0 USD as dividends.

In which currency does Sientra pay out the dividend?

The dividends of Sientra are distributed in USD.

All fundamentals about Sientra

Our stock analysis for Sientra Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sientra Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.